Reported Earlier, AGAPE ATP and FORMEDIC Partner to Launch Advanced Respiratory Device LEGA for COPD and Lung Care
Portfolio Pulse from Benzinga Newsdesk
AGAPE ATP Corporation (ATPC) partners with FORMEDIC Technologies to launch LEGA, an advanced respiratory device for COPD and lung care. This collaboration positions ATPC to capitalize on the growing respiratory care market, projected to reach USD 49.84 billion by 2031.
October 01, 2024 | 7:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AGAPE ATP Corporation partners with FORMEDIC Technologies to launch LEGA, a device for respiratory care, positioning ATPC in the growing respiratory market, projected to reach USD 49.84 billion by 2031.
The partnership with FORMEDIC to launch LEGA positions ATPC to benefit from the growing demand for respiratory solutions. The market is expected to grow significantly, providing ATPC with opportunities to expand its wellness portfolio and increase revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100